S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

XGN Exagen Inc

5.01

-0.01 (-0.20%)

Pre Market

Last Updated: 20:18:41

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Exagen (NASDAQ:XGN)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Exagen Charts.

Exagen (NASDAQ:XGN)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Exagen Charts.

Exagen Inc News

Exagen Inc. to Participate in Upcoming Investor Conferences
Wednesday 5 February 2025 (13 hours ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 30 January 2025 (6 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 14 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results
Monday 13 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD
Friday 13 December 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 20 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (3 months ago) • Edgar (US Regulatory)

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
Friday 15 November 2024 (3 months ago) • GlobeNewswire Inc.

Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Thursday 14 November 2024 (3 months ago) • GlobeNewswire Inc.

Exagen Inc. Reports Third Quarter 2024 Results
Wednesday 13 November 2024 (3 months ago) • GlobeNewswire Inc.

More Exagen Inc News Articles

Woodside Petroleum

JP Morgan Chase

Australia And New Zealan...

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions